Endometrial cancer in relation to intra-uterine device use

International Journal of Cancer

Volumn 70, Issue 3, 1997, Pages 278-281

  Hill, Deirdre A ^a,b   Weiss, Noel S ^a,b   Voigt, Lynda F ^a,b   Beresford, Shirley A A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGE FACTORS; AMERICAS; CANCER; CASE CONTROL STUDIES; CONTRACEPTION; CONTRACEPTIVE HISTORY; CONTRACEPTIVE METHODS--BENEFICIAL EFFECTS; CONTRACEPTIVE USAGE; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; ENDOMETRIAL CANCER; FAMILY PLANNING; IUD--BENEFICIAL EFFECTS; NEOPLASMS; NORTH AMERICA; NORTHERN AMERICA; POPULATION; POPULATION CHARACTERISTICS; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; UNITED STATES; WASHINGTON;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INTRAUTERINE DEVICES; MIDDLE AGED; ODDS RATIO; RISK;

EID: 0031057421     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970127)70:3<278::AID-IJC5>3.0.CO;2-U     Document Type: Article

References (21)

1. AEDO, A.R. and ZIPPER, J., Effect of copper intrauterine devices (IUDs) on estrogen and progesterone uptake by the rat uterus. Fertil. Steril, 24, 345-348 (1973).
2. AMMALA, M., NYMAN, T., STRENGELL, M. and RUTANEN, E.-M., Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium. Fertil. Steril., 63, 773-778 (1995).
3. CASTELLSAGUÉ, X., THOMPSON, W.D. and DUBROW, R., Intra-uterine contra- ception and the risk of endometrial cancer. Int. J. Cancer, 54, 911-916 (1993).
4. DE CASTRO, A. and GONZALEZ-GANCEDO, P., The effect of copper ions in vivo on specific hormonal endometrial receptors. Adv. Contracept., 2, 399-404 (1986).
5. GUILLEBAUD, J., BONNAR, J., MOREHEAD, J. and MATTHEWS, A., Menstrual blood-loss with intrauterine devices. Lancet, 1, 387-390 (1976).
6. HAGENFELDT, K. and LANDGREN, B.M., Local effects of medicated IUDs. In: F. Hefnawi and S.J. Segal (eds), Analysis of intrauterine contraception, pp. 349-354, North Holland/American Elsevier, Amsterdam (1975).
7. LIEDHOLM, P., SRIVASTAVA, K., WINGERUP, L. and ASTEDT, B., Higher fibrinolytic activity in human endometrium in direct contact with an IUD. Acta Obstet. Gynecol. Scand., 62, 169-170 (1983).
8. MOVER, D.L. and MISHELL, D.R., Reactions of human endometrium to the intrauterine foreign body. II. Long-term effects on the endometrial histology and cytology. Amer. J. Obstet. Gynecol., 111, 66-80 (1971).
9. MYATT, L., CHAUDHURI, G., ELDER, M.G. and LIM, L., Effect of an intra-uterine device on intracellular relationships of the uterine oestrogen receptor, particularly during pregnancy. J. Endocrinol., 87, 357-364 (1980a).
10. MYATT, L., ELDER, M.G. and LIM, L., Alterations in progesterone receptors in the rat uterus bearing an intra-uterine device during the oestrous cycle and early pregnancy. J. Endocrinol., 87, 365-373 (1980b).
11. NYGREN, K.-G. and JOHANSSON, E.D., Premature onset of menstrual bleeding during ovulatory cycles in women with an intrauterine contraceptive device. Amer. J. Obstet. Gynecol., 117, 971-975 (1973).
12. PARAZZINI, F., LA VECCHIA, C. and MORONI, S., Intrauterine device use and risk of endometrial cancer. Brit. J. Cancer, 70, 672-673 (1994).
13. PUNNONEN, R., PETTERSSON, K. and VANHARANTA, R., Androgen, estrogen and progestin cytosol receptor concentrations in the normal human endometrium. Gynecol. Obstet. Invest., 17, 73-77 (1984).
14. ROSENBLATT, K.A., THOMAS, D.B. and THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES, Intrauterine device use and endometrial cancer [Abstract]. Amer. J. Epidemiol., 139 (Suppl.), S36 (1994).
15. SHAH, I.H., The advance of the contraceptive revolution. World Health Statist. Quart., 47, 9-15 (1994).
16. SHAW, S.T. and MACAULAY, L.K., Morphologic studies on IUD-induced metrorrhagia. II. Surface changes of the endometrium and microscopic localization of bleeding sites. Contraception, 19, 63-81 (1979).
17. SHU, X., BRINTON, L.A., ZHENG, W., GAO, Y.T. and FRAUMENI, J.F., A population-based case-control study of endometrial cancer in Shanghai, China. Int. J. Cancer, 49, 38-43 (1991).
18. TATUM, H.J. and CONNELL, E.B., Intrauterine contraceptive devices. In: M. Filshie and J. Guillebaud (eds), Contraception: science and practice, pp. 160-161, Butterworths, London (1989).
19. TOPPOZADA, M., Prostaglandins and their inhibitors in IUD-induced bleeding. In: G.I. Zatuchni, A. Goldsmith and J.J. Sciarra (eds), Intrauterine contraception: advances and future prospects, pp. 319-334, Harper and Row, Philadelphia (1985).
20. WAKSBERG, J., Sampling methods for random digit dialing. J. Amer. Statist. Assoc., 73, 40-46 (1978).
21. WEISS, N. and ROSSING, M., Healthy screening bias in epidemiologic studies of cancer incidence. Epidemiology, 7, 319-322 (1996).